
@ShahidNShah
n the midst of the digital health era, the pharmaceutical industry has been experiencing a rapid evolution. Thanks to the new paradigms that novel healthcare delivery approaches and digital health technologies have brought about, pharma companies need to adopt new strategies and consider new investment opportunities to stay relevant in the ever-evolving healthcare landscape.
In this article, we cover 8 major trends for pharma companies to consider in the digital health era. We rank them based on their return-on-investment (ROI) and return-on-vision (ROV). The latter is particularly relevant in this era considering its rapid rate of evolution.
To better appreciate the importance of ROV, we can consider the Apollo program. While it was focused on space exploration, the endeavour has resulted in a multitude of spin-off products across various fields. In the healthcare sector, those spin-offs range from medical imaging to innovations in dental care.
Continue reading at medicalfuturist.com
As healthcare organizations grapple with rising costs and evolving payment models, achieving positive margins is more critical than ever. The Peter G. Peterson Foundation reports that the …
Posted Nov 15, 2024 Industry Healthcare
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm